Unprecedented Accuracy.
Real-Time Clarity.
For the first time, researchers can see senescent cell activity inside living tissue — without biopsy or delay. PreDx’s technology transforms static snapshots into dynamic, cellular-level insight that accelerates drug development and clinical decision-making.
Empower Your Trials. De-Risk Development.
Follow the effect of your senescent cell treatment in the same subjects over time. Using PreDx's technology, researchers can more effectively evaluate the efficacy of treatments through real-time monitoring of senescent cell activity.
De-risk Development
The only technology that non-invasively quantifies the presence and activity levels of senescent cells.
Reduce Costs and Uncertainty
No need to wait for physiological symptoms to present. Detect senescent cells early and monitor their impact continuously.
Accelerate Preclinical and Clinical Trials
Paves the way for FDA-approved imaging markers tied to therapeutic outcomes.